Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males

Detalhes bibliográficos
Autor(a) principal: Oliveira, J
Data de Publicação: 2020
Outros Autores: Nowak, A, Barbey, F, Torres, M, Nunes, J, Teixeira-e-Costa, F, Carvalho, F, Sampaio, S, Tavares, I, Pereira, O, Soares, A, Carmona, C, Cardoso, MT, Jurca-Simina, I, Spada, M, Ferreira, S, Germain, D
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4420
Resumo: Background, aims and methods: The α-galactosidase gene (GLA) c.337T>C/p.Phe113Leu variant was originally described in patients with late-onset cardiac forms of Fabry disease (FD), who had residual α-galactosidase activity. It has since emerged as the most commonly reported GLA variant in Portuguese subjects diagnosed with FD but is also prevalent in the Italian population, where two boys carrying the GLA Leu113 allele were identified in a large-scale newborn screening program, the variant allele segregating in both cases with the same surrounding haplotype. To further delineate the genotype-phenotype correlations of this GLA variant, we have reviewed the natural history and clinical phenotypes of 11 symptomatic Portuguese males, from 10 unrelated families originating from several different areas in mainland Portugal and Madeira Island, who were diagnosed with FD associated with the GLA Leu113 allele in a diversity of clinical and screening settings. Nine of the patients were the probands of their respective families. To test whether the GLA Leu113 allele inherited by the 10 Portuguese and the two Italian families resulted from independent mutational events, we have additionally performed a haplotype analysis with 5 highly polymorphic, closely linked microsatellite markers surrounding the GLA gene. Results and conclusions: Hemizygosity for the GLA Leu113 variant allele is associated with a late-onset form of FD, invariably presenting with severe cardiac involvement. Clinically relevant cerebrovascular and kidney involvement may also occur in some patients but the pathogenic relationship between the incomplete α-galactosidase deficiency and the risks of stroke and of chronic kidney disease is not straightforward. The observation that the Leu113 allele segregated within the same GLA microsatellite haplotype in both the Portuguese and Italian families suggests its inheritance from a common ancestor.
id RCAP_13d9fb9bf1bbf00d9b4a6282e34d4b74
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4420
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in MalesHCC NEFAdultAgedMaleAllelesMiddle AgedHumansCardiovascular Diseases / complicationsCardiovascular Diseases / geneticsCardiovascular Diseases / metabolismCerebrovascular Disorders / complicationsCerebrovascular Disorders / geneticsCerebrovascular Disorders / metabolismFabry Disease / complicationsFabry Disease / diagnosis*Fabry Disease / diagnostic imagingFabry Disease / genetics*GenotypeGenetic Association StudiesHaplotypesItaly / epidemiologyMicrosatellite Repeats / geneticsMutationMyocytes, Cardiac / pathologyMyocytes, Cardiac / ultrastructurePhenotypePortugal / epidemiologyRenal Insufficiency, Chronic / complicationsRenal Insufficiency, Chronic / geneticsRenal Insufficiency, Chronic / metabolismRisk Factorsalpha-Galactosidase / genetics*alpha-Galactosidase / metabolism*Background, aims and methods: The α-galactosidase gene (GLA) c.337T>C/p.Phe113Leu variant was originally described in patients with late-onset cardiac forms of Fabry disease (FD), who had residual α-galactosidase activity. It has since emerged as the most commonly reported GLA variant in Portuguese subjects diagnosed with FD but is also prevalent in the Italian population, where two boys carrying the GLA Leu113 allele were identified in a large-scale newborn screening program, the variant allele segregating in both cases with the same surrounding haplotype. To further delineate the genotype-phenotype correlations of this GLA variant, we have reviewed the natural history and clinical phenotypes of 11 symptomatic Portuguese males, from 10 unrelated families originating from several different areas in mainland Portugal and Madeira Island, who were diagnosed with FD associated with the GLA Leu113 allele in a diversity of clinical and screening settings. Nine of the patients were the probands of their respective families. To test whether the GLA Leu113 allele inherited by the 10 Portuguese and the two Italian families resulted from independent mutational events, we have additionally performed a haplotype analysis with 5 highly polymorphic, closely linked microsatellite markers surrounding the GLA gene. Results and conclusions: Hemizygosity for the GLA Leu113 variant allele is associated with a late-onset form of FD, invariably presenting with severe cardiac involvement. Clinically relevant cerebrovascular and kidney involvement may also occur in some patients but the pathogenic relationship between the incomplete α-galactosidase deficiency and the risks of stroke and of chronic kidney disease is not straightforward. The observation that the Leu113 allele segregated within the same GLA microsatellite haplotype in both the Portuguese and Italian families suggests its inheritance from a common ancestor.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEOliveira, JNowak, ABarbey, FTorres, MNunes, JTeixeira-e-Costa, FCarvalho, FSampaio, STavares, IPereira, OSoares, ACarmona, CCardoso, MTJurca-Simina, ISpada, MFerreira, SGermain, D2023-02-22T15:26:57Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4420engEur J Med Genet . 2020 Feb;63(2):103703.10.1016/j.ejmg.2019.103703info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:46:23Zoai:repositorio.chlc.min-saude.pt:10400.17/4420Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:21:46.426315Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males
title Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males
spellingShingle Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males
Oliveira, J
HCC NEF
Adult
Aged
Male
Alleles
Middle Aged
Humans
Cardiovascular Diseases / complications
Cardiovascular Diseases / genetics
Cardiovascular Diseases / metabolism
Cerebrovascular Disorders / complications
Cerebrovascular Disorders / genetics
Cerebrovascular Disorders / metabolism
Fabry Disease / complications
Fabry Disease / diagnosis*
Fabry Disease / diagnostic imaging
Fabry Disease / genetics*
Genotype
Genetic Association Studies
Haplotypes
Italy / epidemiology
Microsatellite Repeats / genetics
Mutation
Myocytes, Cardiac / pathology
Myocytes, Cardiac / ultrastructure
Phenotype
Portugal / epidemiology
Renal Insufficiency, Chronic / complications
Renal Insufficiency, Chronic / genetics
Renal Insufficiency, Chronic / metabolism
Risk Factors
alpha-Galactosidase / genetics*
alpha-Galactosidase / metabolism*
title_short Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males
title_full Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males
title_fullStr Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males
title_full_unstemmed Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males
title_sort Fabry Disease Caused by the GLA p.Phe113Leu (p.F113L) Variant: Natural History in Males
author Oliveira, J
author_facet Oliveira, J
Nowak, A
Barbey, F
Torres, M
Nunes, J
Teixeira-e-Costa, F
Carvalho, F
Sampaio, S
Tavares, I
Pereira, O
Soares, A
Carmona, C
Cardoso, MT
Jurca-Simina, I
Spada, M
Ferreira, S
Germain, D
author_role author
author2 Nowak, A
Barbey, F
Torres, M
Nunes, J
Teixeira-e-Costa, F
Carvalho, F
Sampaio, S
Tavares, I
Pereira, O
Soares, A
Carmona, C
Cardoso, MT
Jurca-Simina, I
Spada, M
Ferreira, S
Germain, D
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Oliveira, J
Nowak, A
Barbey, F
Torres, M
Nunes, J
Teixeira-e-Costa, F
Carvalho, F
Sampaio, S
Tavares, I
Pereira, O
Soares, A
Carmona, C
Cardoso, MT
Jurca-Simina, I
Spada, M
Ferreira, S
Germain, D
dc.subject.por.fl_str_mv HCC NEF
Adult
Aged
Male
Alleles
Middle Aged
Humans
Cardiovascular Diseases / complications
Cardiovascular Diseases / genetics
Cardiovascular Diseases / metabolism
Cerebrovascular Disorders / complications
Cerebrovascular Disorders / genetics
Cerebrovascular Disorders / metabolism
Fabry Disease / complications
Fabry Disease / diagnosis*
Fabry Disease / diagnostic imaging
Fabry Disease / genetics*
Genotype
Genetic Association Studies
Haplotypes
Italy / epidemiology
Microsatellite Repeats / genetics
Mutation
Myocytes, Cardiac / pathology
Myocytes, Cardiac / ultrastructure
Phenotype
Portugal / epidemiology
Renal Insufficiency, Chronic / complications
Renal Insufficiency, Chronic / genetics
Renal Insufficiency, Chronic / metabolism
Risk Factors
alpha-Galactosidase / genetics*
alpha-Galactosidase / metabolism*
topic HCC NEF
Adult
Aged
Male
Alleles
Middle Aged
Humans
Cardiovascular Diseases / complications
Cardiovascular Diseases / genetics
Cardiovascular Diseases / metabolism
Cerebrovascular Disorders / complications
Cerebrovascular Disorders / genetics
Cerebrovascular Disorders / metabolism
Fabry Disease / complications
Fabry Disease / diagnosis*
Fabry Disease / diagnostic imaging
Fabry Disease / genetics*
Genotype
Genetic Association Studies
Haplotypes
Italy / epidemiology
Microsatellite Repeats / genetics
Mutation
Myocytes, Cardiac / pathology
Myocytes, Cardiac / ultrastructure
Phenotype
Portugal / epidemiology
Renal Insufficiency, Chronic / complications
Renal Insufficiency, Chronic / genetics
Renal Insufficiency, Chronic / metabolism
Risk Factors
alpha-Galactosidase / genetics*
alpha-Galactosidase / metabolism*
description Background, aims and methods: The α-galactosidase gene (GLA) c.337T>C/p.Phe113Leu variant was originally described in patients with late-onset cardiac forms of Fabry disease (FD), who had residual α-galactosidase activity. It has since emerged as the most commonly reported GLA variant in Portuguese subjects diagnosed with FD but is also prevalent in the Italian population, where two boys carrying the GLA Leu113 allele were identified in a large-scale newborn screening program, the variant allele segregating in both cases with the same surrounding haplotype. To further delineate the genotype-phenotype correlations of this GLA variant, we have reviewed the natural history and clinical phenotypes of 11 symptomatic Portuguese males, from 10 unrelated families originating from several different areas in mainland Portugal and Madeira Island, who were diagnosed with FD associated with the GLA Leu113 allele in a diversity of clinical and screening settings. Nine of the patients were the probands of their respective families. To test whether the GLA Leu113 allele inherited by the 10 Portuguese and the two Italian families resulted from independent mutational events, we have additionally performed a haplotype analysis with 5 highly polymorphic, closely linked microsatellite markers surrounding the GLA gene. Results and conclusions: Hemizygosity for the GLA Leu113 variant allele is associated with a late-onset form of FD, invariably presenting with severe cardiac involvement. Clinically relevant cerebrovascular and kidney involvement may also occur in some patients but the pathogenic relationship between the incomplete α-galactosidase deficiency and the risks of stroke and of chronic kidney disease is not straightforward. The observation that the Leu113 allele segregated within the same GLA microsatellite haplotype in both the Portuguese and Italian families suggests its inheritance from a common ancestor.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01T00:00:00Z
2023-02-22T15:26:57Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4420
url http://hdl.handle.net/10400.17/4420
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Eur J Med Genet . 2020 Feb;63(2):103703.
10.1016/j.ejmg.2019.103703
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131312826613760